Logo image of MPW

MEDICAL PROPERTIES TRUST INC (MPW) Stock Fundamental Analysis

USA - NYSE:MPW - US58463J3041 - REIT

5.185 USD
+0.01 (+0.29%)
Last: 11/3/2025, 11:51:57 AM
Fundamental Rating

4

Taking everything into account, MPW scores 4 out of 10 in our fundamental rating. MPW was compared to 127 industry peers in the Diversified REITs industry. While MPW seems to be doing ok healthwise, there are quite some concerns on its profitability. MPW is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MPW has reported negative net income.
MPW had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MPW reported negative net income in multiple years.
In the past 5 years MPW always reported a positive cash flow from operatings.
MPW Yearly Net Income VS EBIT VS OCF VS FCFMPW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

1.2 Ratios

MPW's Return On Assets of -9.45% is on the low side compared to the rest of the industry. MPW is outperformed by 89.76% of its industry peers.
MPW has a Return On Equity of -29.62%. This is amonst the worse of the industry: MPW underperforms 88.98% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.93%, MPW is doing worse than 66.93% of the companies in the same industry.
MPW had an Average Return On Invested Capital over the past 3 years of 2.26%. This is in line with the industry average of 3.06%.
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROIC 1.93%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
MPW Yearly ROA, ROE, ROICMPW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With an excellent Operating Margin value of 38.49%, MPW belongs to the best of the industry, outperforming 83.46% of the companies in the same industry.
MPW's Operating Margin has declined in the last couple of years.
MPW's Gross Margin of 96.46% is amongst the best of the industry. MPW outperforms 97.64% of its industry peers.
In the last couple of years the Gross Margin of MPW has remained more or less at the same level.
Industry RankSector Rank
OM 38.49%
PM (TTM) N/A
GM 96.46%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
MPW Yearly Profit, Operating, Gross MarginsMPW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MPW is destroying value.
Compared to 1 year ago, MPW has more shares outstanding
The number of shares outstanding for MPW has been increased compared to 5 years ago.
The debt/assets ratio for MPW is higher compared to a year ago.
MPW Yearly Shares OutstandingMPW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
MPW Yearly Total Debt VS Total AssetsMPW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.01, we must say that MPW is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.01, MPW is doing worse than 75.59% of the companies in the same industry.
The Debt to FCF ratio of MPW is 931.91, which is on the high side as it means it would take MPW, 931.91 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 931.91, MPW perfoms like the industry average, outperforming 52.76% of the companies in the same industry.
MPW has a Debt/Equity ratio of 2.00. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.00, MPW is not doing good in the industry: 70.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Altman-Z 0.01
ROIC/WACC0.32
WACC6.11%
MPW Yearly LT Debt VS Equity VS FCFMPW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

MPW has a Current Ratio of 2.07. This indicates that MPW is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.07, MPW belongs to the best of the industry, outperforming 80.31% of the companies in the same industry.
MPW has a Quick Ratio of 2.07. This indicates that MPW is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MPW (2.07) is better than 80.31% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 2.07
MPW Yearly Current Assets VS Current LiabilitesMPW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.50% over the past year.
Looking at the last year, MPW shows a quite strong growth in Revenue. The Revenue has grown by 14.19% in the last year.
MPW shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.11% yearly.
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%

3.2 Future

The Earnings Per Share is expected to grow by 27.84% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.71% on average over the next years.
EPS Next Y90.15%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MPW Yearly Revenue VS EstimatesMPW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
MPW Yearly EPS VS EstimatesMPW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

3

4. Valuation

4.1 Price/Earnings Ratio

MPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 33.34, which means the current valuation is very expensive for MPW.
MPW's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MPW is cheaper than 70.87% of the companies in the same industry.
MPW's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.55.
Industry RankSector Rank
PE N/A
Fwd PE 33.34
MPW Price Earnings VS Forward Price EarningsMPW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

MPW's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. MPW is more expensive than 61.42% of the companies in the same industry.
MPW's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 301.01
EV/EBITDA 16.09
MPW Per share dataMPW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MPW's earnings are expected to grow with 27.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.49%
EPS Next 3Y27.84%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.19%, MPW is a good candidate for dividend investing.
MPW's Dividend Yield is a higher than the industry average which is at 6.40.
Compared to an average S&P500 Dividend Yield of 2.37, MPW pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.19%

5.2 History

The dividend of MPW decreases each year by -10.38%.
MPW has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-10.38%
Div Incr Years0
Div Non Decr Years0
MPW Yearly Dividends per shareMPW Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MPW has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-16.42%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
MPW Yearly Income VS Free CF VS DividendMPW Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B -4B

MEDICAL PROPERTIES TRUST INC

NYSE:MPW (11/3/2025, 11:51:57 AM)

5.185

+0.01 (+0.29%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners59.4%
Inst Owner Change0.21%
Ins Owners17.29%
Ins Owner Change-0.29%
Market Cap3.12B
Revenue(TTM)995.55M
Net Income(TTM)-1431276000
Analysts51.76
Price Target4.95 (-4.53%)
Short Float %31.38%
Short Ratio18.66
Dividend
Industry RankSector Rank
Dividend Yield 6.19%
Yearly Dividend0.54
Dividend Growth(5Y)-10.38%
DP-16.42%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-11 2025-09-11 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5843.9%
Min EPS beat(2)-11757.5%
Max EPS beat(2)69.68%
EPS beat(4)1
Avg EPS beat(4)-3817.81%
Min EPS beat(4)-11757.5%
Max EPS beat(4)69.68%
EPS beat(8)2
Avg EPS beat(8)-1947.02%
EPS beat(12)3
Avg EPS beat(12)-1329.14%
EPS beat(16)7
Avg EPS beat(16)-980.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-3.58%
Max Revenue beat(2)2.15%
Revenue beat(4)2
Avg Revenue beat(4)-1.37%
Min Revenue beat(4)-9.56%
Max Revenue beat(4)5.51%
Revenue beat(8)4
Avg Revenue beat(8)-0.64%
Revenue beat(12)5
Avg Revenue beat(12)-1.65%
Revenue beat(16)6
Avg Revenue beat(16)-1.31%
PT rev (1m)0%
PT rev (3m)-5.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-65.39%
EPS NY rev (1m)-56.06%
EPS NY rev (3m)-485.23%
Revenue NQ rev (1m)0.64%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.34
P/S 3.38
P/FCF 301.01
P/OCF 16.58
P/B 0.64
P/tB 0.64
EV/EBITDA 16.09
EPS(TTM)-1
EYN/A
EPS(NY)0.16
Fwd EY3%
FCF(TTM)0.02
FCFY0.33%
OCF(TTM)0.31
OCFY6.03%
SpS1.53
BVpS8.04
TBVpS8.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.45%
ROE -29.62%
ROCE 2.45%
ROIC 1.93%
ROICexc 2%
ROICexgc 2.08%
OM 38.49%
PM (TTM) N/A
GM 96.46%
FCFM 1.12%
ROA(3y)-5.11%
ROA(5y)-1.92%
ROE(3y)-15.57%
ROE(5y)-6.62%
ROIC(3y)2.26%
ROIC(5y)2.99%
ROICexc(3y)2.3%
ROICexc(5y)3.06%
ROICexgc(3y)2.37%
ROICexgc(5y)3.14%
ROCE(3y)2.86%
ROCE(5y)3.79%
ROICexgc growth 3Y-18.25%
ROICexgc growth 5Y-8.72%
ROICexc growth 3Y-18.71%
ROICexc growth 5Y-8.92%
OM growth 3Y-16.71%
OM growth 5Y-10.61%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y-0.02%
F-Score4
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 931.91
Debt/EBITDA 12.68
Cap/Depr 43.72%
Cap/Sales 19.27%
Interest Coverage 0.92
Cash Conversion 24.7%
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 2.07
Altman-Z 0.01
F-Score4
WACC6.11%
ROIC/WACC0.32
Cap/Depr(3y)171.64%
Cap/Depr(5y)740.47%
Cap/Sales(3y)50.73%
Cap/Sales(5y)169.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.3%
EPS Next Y90.15%
EPS Next 2Y43.49%
EPS Next 3Y27.84%
EPS Next 5YN/A
Revenue 1Y (TTM)14.19%
Revenue growth 3Y-13.62%
Revenue growth 5Y3.11%
Sales Q2Q%5.18%
Revenue Next Year-4.88%
Revenue Next 2Y2.14%
Revenue Next 3Y3.65%
Revenue Next 5Y2.71%
EBIT growth 1Y54.29%
EBIT growth 3Y-28.05%
EBIT growth 5Y-7.83%
EBIT Next Year124.92%
EBIT Next 3Y37.51%
EBIT Next 5Y20.65%
FCF growth 1Y116.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.04%
OCF growth 3Y-32.88%
OCF growth 5Y-13.06%

MEDICAL PROPERTIES TRUST INC / MPW FAQ

What is the fundamental rating for MPW stock?

ChartMill assigns a fundamental rating of 4 / 10 to MPW.


What is the valuation status for MPW stock?

ChartMill assigns a valuation rating of 3 / 10 to MEDICAL PROPERTIES TRUST INC (MPW). This can be considered as Overvalued.


Can you provide the profitability details for MEDICAL PROPERTIES TRUST INC?

MEDICAL PROPERTIES TRUST INC (MPW) has a profitability rating of 3 / 10.


What is the financial health of MEDICAL PROPERTIES TRUST INC (MPW) stock?

The financial health rating of MEDICAL PROPERTIES TRUST INC (MPW) is 4 / 10.


Can you provide the expected EPS growth for MPW stock?

The Earnings per Share (EPS) of MEDICAL PROPERTIES TRUST INC (MPW) is expected to grow by 90.15% in the next year.